Symptomatic Bradycardia Due to Alectinib in a Patient with Advanced Stage of NSCLC

Alectinib is one of the targeted therapies commonly given to patients with advanced non-small cell lung cancer (NSCLC) with mutations in the ALK gene. The most common adverse effects of alectinib are fatigue, constipation, edema, myalgia and anemia. Meanwhile, bradycardia was reported as a very comm...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Ceva Wicaksono Pitoyo (Autor), Cleopas Martin Rumende (Autor), Anindita Kartika Wiraputri (Autor), Fatira Ratri Audita (Autor)
Format: Knjiga
Izdano: Interna Publishing, 2022-04-01T00:00:00Z.
Teme:
Online pristup:Connect to this object online.
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Internet

Connect to this object online.

3rd Floor Main Library

Detalji primjeraka od 3rd Floor Main Library
Signatura: A1234.567
Primjerak 1 Dostupno